Ch14.18

dacetuzumab? (Note: Ch14.18 is dinutuximab beta or similar; please verify exact derivative)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ch14.18, covering 2015-02-19 to 2015-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma [Phase 3]

See pricing